|Articles|March 1, 2003

March 2003
Volume 9
Issue 3

Slow Response to Loss of Glycemic Control in Type 2 Diabetes Mellitus

Author(s)Jonathan B. Brown, PhD, MPP, Gregory A. Nichols, PhD

Download PDF: Slow Response to Loss of Glycemic Control in Type 2 Diabetes Mellitus

Articles in this issue

over 23 years ago

Article

How Do Minor Changes in the Definition of Blood Pressure Control Affect the Reported Success of Hypertension Treatment?

over 23 years ago

Article

Physician Attitudes Toward Strategies to Promote the Adoption of Medical Evidence Into Clinical Practice

over 23 years ago

Article

Patient Reports of Coverage Denial: Association With Ratings of Health Plan Quality and Trust in Physician

over 23 years ago

Article

Restoring Trust to Managed Care, Part 2: A Focus on Physicians

over 23 years ago

Article

Review of the Newer Antiepileptic Drugs

Newsletter

Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.

Subscribe

Related Content

Roles and Priorities Guiding Medicare Advantage Postacute Home Health Referrals

ByEmily A. Gadbois, PhD,Jennifer Bunker, MPH,Marguerite Daus, PhD, RN,Jamie M. Smith, PhD, RN,Emily Buss, MSN, RN,Christine D. Jones, MD, MS,Kali S. Thomas, PhD, MA

July 16th 2026

Reply to Letter Regarding “Preventive Dental Care and Overall Medical Expenditures”

ByHeather L. Taylor, MPH, LDH,Ann M. Holmes, PhD,Nir Menachemi, PhD, MPH,Justin Blackburn, PhD

July 10th 2026

Changes in Semaglutide Fills Following Expanded FDA and Medicare Policies

ByChristopher Scannell, MD, PhD,John A. Romley, PhD,Rebecca Myerson, PhD,Dana Goldman, PhD,Dima Mazen Qato, PharmD, PhD, MPH

July 9th 2026

Upper Payment Limit Implementation Risks for Patients, Pharmacies, and Providers

ByJulie A. Patterson, PharmD, PhD,Roswell A. Cole, PharmD, MPH,Jonathan D. Campbell, PhD, MS,John Michael O’Brien, PharmD, MPH

July 9th 2026

The New Oncology Blueprint: Integrating Clinical Intelligence for Sustainable Value

ByVivian T. E. Tar, PharmD, MBA

July 8th 2026

Slow Response to Loss of Glycemic Control in Type 2 Diabetes Mellitus

Articles in this issue

Related Content

Roles and Priorities Guiding Medicare Advantage Postacute Home Health Referrals

Reply to Letter Regarding “Preventive Dental Care and Overall Medical Expenditures”

Changes in Semaglutide Fills Following Expanded FDA and Medicare Policies

Upper Payment Limit Implementation Risks for Patients, Pharmacies, and Providers

The New Oncology Blueprint: Integrating Clinical Intelligence for Sustainable Value

Trending on AJMC

FDA Approves Enlicitide, First Oral PCSK9 for High Cholesterol

SYNCHRONIZE-1 Through a Hepatologist's Lens: Liver Fat Reduction, Visceral Fat, and What Comes Next

Home-Based Heart Failure Care Shows Comparable Safety to Continued Inpatient Care

Voice Biomarkers Show Promise for Asthma, COPD Exacerbation Detection

Beyond GLP-1: The Biological Case for Dual Incretin Therapy in MASH